Synergistic Action of Heat-Shock Protein-90 Inhibitor NVP-AUY922 with Histone Deacetylase Inhibition

被引:0
|
作者
Kaiser, M. [1 ]
Lamottke, B. [1 ]
Jensen, M. R. [2 ]
Quadt, C. [3 ]
Garcia-Echeverria, C. [3 ]
Mieth, M. [1 ]
Heider, U. [1 ]
Sezer, O. [1 ]
机构
[1] Charite Univ Med Berlin, D-13353 Berlin, Germany
[2] Novartis Inst BioMed Res, Basel, Switzerland
[3] Novartis Pharma AG, Early Clin Dev, Basel, Switzerland
来源
关键词
D O I
10.1016/S1557-9190(11)70721-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S129 / S129
页数:1
相关论文
共 50 条
  • [1] Synergistic action of the novel HSP90 inhibitor NVP-AUY922 with histone deacetylase inhibitors, melphalan, or doxorubicin in multiple myeloma
    Kaiser, Martin
    Lamottke, Britta
    Mieth, Maren
    Jensen, Michael R.
    Quadt, Cornelia
    Garcia-Echeverria, Carlos
    Atadja, Peter
    Heider, Ulrike
    von Metzler, Ivana
    Tuerkmen, Seval
    Sezer, Orhan
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2010, 84 (04) : 337 - 344
  • [2] Heat-shock protein (Hsp) 70 inhibition enhances the effect of the Hsp90 inhibitor NVP-AUY922 on melanoma cells
    Yeramian, A.
    Vea, A.
    Santacana, M.
    Matias-Guiu, X.
    Marti, R. M.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 (03) : E48 - E48
  • [3] Heat-shock protein (Hsp)70 inhibition enhances the effect of the Hsp90 inhibitor NVP-AUY922 on melanoma cells
    Yeramian, A.
    Vea, A.
    Santacana, M.
    Matias-Guiu, X.
    Marti, R. M.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 171 : 36 - 36
  • [4] Novel Heat Shock Protein 90 Inhibitor NVP-AUY922 Synergizes With the Histone Deacetylase Inhibitor PXD101 in Induction of Death of Anaplastic Thyroid Carcinoma Cells
    Kim, Si Hyoung
    Kang, Jun Goo
    Kim, Chul Sik
    Ihm, Sung-Hee
    Choi, Moon Gi
    Yoo, Hyung Joon
    Lee, Seong Jin
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (02): : E253 - E261
  • [5] Combined effects of novel heat shock protein 90 inhibitor NVP-AUY922 and nilotinib in a random mutagenesis screen
    Tauchi, T.
    Okabe, S.
    Ashihara, E.
    Kimura, S.
    Maekawa, T.
    Ohyashiki, K.
    ONCOGENE, 2011, 30 (24) : 2789 - 2797
  • [6] Combined effects of novel heat shock protein 90 inhibitor NVP-AUY922 and nilotinib in a random mutagenesis screen
    T Tauchi
    S Okabe
    E Ashihara
    S Kimura
    T Maekawa
    K Ohyashiki
    Oncogene, 2011, 30 : 2789 - 2797
  • [7] Combined Effects of novel Heat Shock Protein 90 Inhibitor NVP-AUY922 and Nilotinib in a Random Mutagenesis Screen.
    Tauchi, Tetsuzo
    Okabe, Seiichi
    Ashihara, Eishi
    Kimura, Shinya
    Maekawa, Taira
    Ohyashiki, Kazuma
    BLOOD, 2009, 114 (22) : 1449 - 1449
  • [8] NVP-AUY922: A novel heat shock protein 90 inhibitor active against xenograft tumor growth, angiogenesis, and metastasis
    Eccles, Suzanne A.
    Massey, Andy
    Raynaud, Florence I.
    Sharp, Swee Y.
    Box, Gary
    Valenti, Melanie
    Patterson, Lisa
    Brandon, Alexis de Haven
    Gowan, Sharon
    Boxall, Frances
    Aherne, Wynne
    Rowlands, Martin
    Hayes, Angela
    Martins, Vanessa
    Urban, Frederique
    Boxall, Kathy
    Prodromou, Chrisostomos
    Pearl, Laurence
    James, Karen
    Matthews, Thomas P.
    Cheung, Kwai-Ming
    Kalusa, Andrew
    Jones, Keith
    McDonald, Edward
    Barril, Xavier
    Brough, Paul A.
    Cansfield, Julie E.
    Dymock, Brian
    Drysdale, Martin J.
    Finch, Harry
    Howes, Rob
    Hubbard, Roderick E.
    Surgenor, Alan
    Webb, Paul
    Wood, Mike
    Wright, Lisa
    Workman, Paul
    CANCER RESEARCH, 2008, 68 (08) : 2850 - 2860
  • [9] Combined Effects of Novel Heat Shock Protein 90 Inhibitor NVP-AUY922 and Nilotinib against Mutant Forms of BCR-ABL
    Tauchi, Tetsuzo
    Akahane, Daigo
    Okabe, Sciichi
    Ashihara, Eishi
    Kimura, Shinya
    Maekawa, Taira
    Ohyashiki, Kazuma
    BLOOD, 2008, 112 (11) : 269 - 269
  • [10] Evaluation of the synthetic heat shock protein 90 inhibitors NVP-AUY922 and NVP-HSP990 in human prostate cancer tissue
    Centenera, M. M.
    Treloar, J. L.
    Hanson, A.
    Sutherland, P.
    Tilley, W. D.
    Butler, L. M.
    EJC SUPPLEMENTS, 2010, 8 (07): : 28 - 28